The IOF Advanced Training Course on Osteoporosis

Programme | Accommodation and Course Meals | Registration Fees | About Lyon | General Terms and Conditions

The IOF Advanced Training Course on Osteoporosis, taught in English by an internationally renowned faculty, provides a concise and practical overview of the latest knowledge on the physiology, epidemiology, diagnosis and management of osteoporosis. The two-and-a-half day course, held annually in Lyon since 1991, trains up to 250 international participants. It is aimed at medical and allied health professionals as well as participants from pharmaceutical and diagnostic industries. Discussion periods, roundtable discussions and meet-the-professor sessions are included throughout the program to encourage direct interactions between registered participants and faculty members.

• Lectures are 20 or 30 minutes in length followed by 10 or 15 minutes of discussion, respectively.
• Roundtable sessions address oral and written questions from the audience.
• Meet-the-Professor sessions are informal discussions between small groups of participants and a faculty member during lunch.

Participants are eligible for EACCME accreditation (see right side bar).

The course is held in Lyon. Visit www.lyon-france.com for further information.

Up to 20 grants are available to healthcare professionals, affiliated to IOF member societies.
Please contact your national society directly.

Course Leader: S.E. Papapoulos

Teaching Faculty

S. BOONEN	E.V. McCLOSKEY
Division of Geriatric Medicine & Center for Metabolic Bone Diseases University Hospitals Leuven Leuven, BE	WHO Collaborating Centre for Metabolic Bone Diseases University of Sheffield Sheffield, UK
M.L. BOUXSEIN	M.R. McCLUNG
Department of Orthopedic Surgery Harvard Medical School Boston, US	Oregon Osteoporosis Center Portland, US
C. COOPER	S.E. PAPAPOULOS
MRC Epidemiology Resource Centre University of Southampton Southampton, UK	Department of Endocrinology & Metabolic Diseases Leiden University Medical Center Leiden, NL
W.H. DERE	J.Y. REGINSTER
Amgen Inc. Uxbridge, UK	Department of Public Health, Epidemiology & Health Economics University of Liège Liège, BE
J.A. KANIS	R. RIZZOLI
WHO Collaborating Centre for Metabolic Bone Diseases University of Sheffield Sheffield, UK	Division of Bone Diseases Department of Rehabilitation & Geriatrics Geneva University Hospital Geneva, CH